International Clinical Trial: Impact of COVID-19 pandemic on status epilepticus: changes in etiology spectrum, clinical features and prognosis

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118170) titled 'Impact of COVID-19 pandemic on status epilepticus: changes in etiology spectrum, clinical features and prognosis' on Feb. 3.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Chinese Academy of Medical Sciences, Peking Union Medical College Hospital

Condition: Status epilepticus

Intervention: Pre-COVID(group 1):None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-15

Target Sample Size: Pre-COVID(group 1):249;Post-COVID(group 2):250;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=306511

Dis...